• Home
  • About Us
  • Health Insurance Companies

Health Plan News

Timely Health Plan News and Commmentary.

Health Plan News
Home Archives for Annalyn Frame

CONMED Corporation to Announce Third Quarter 2010 Financial Results on October 28, 2010

Posted on October 6, 2010 Written by Annalyn Frame

SOURCE: CONMED Corporation

UTICA, NY–(Marketwire – October 6, 2010) –  CONMED Corporation (NASDAQ: CNMD) announced today that it expects to report third quarter 2010 financial results before the market opens on Thursday, October 28, 2010, and will also hold a conference call live over the Internet at 10:00 a.m. Eastern Time that same day. This webcast can be accessed from CONMED’s web site at www.conmed.com. Replays of the call will be made available through November 5, 2010.

The Company anticipates that forward-looking information and additional material details related to third quarter 2010 earnings and the Company’s expectations on a prospective basis may be discussed during the call. Such forward-looking information may involve risks and uncertainties such as those described in the Company’s SEC filings.

CONMED is a medical technology company with an emphasis on surgical devices and equipment for minimally invasive procedures and monitoring. The Company’s products serve the clinical areas of sports medicine-arthroscopy, powered surgical instruments, electrosurgery, cardiac monitoring disposables, endosurgery and endoscopic technologies. Surgeons and physicians in a variety of specialties including orthopedics, general surgery, gynecology, neurosurgery, and gastroenterology use our medical devices. Headquartered in Utica, New York, the Company’s 3,300 employees distribute its products worldwide from several manufacturing locations.

CONTACT:

CONMED Corporation
Robert Shallish
Chief Financial Officer
315-624-3206

FD
Brian Ritchie
212-850-5600

Filed Under: Facilities And Providers

Riverside Now Raising the Bar on South Chicago Illinois Healthcare

Posted on October 6, 2010 Written by Annalyn Frame

SOURCE: Riverside Medical Center

KANKAKEE, IL–(Marketwire – October 5, 2010) – Riverside Medical Center has now joined the Illinois Hospital Association’s (IHA) “Raising the Bar” initiative to continue improving the level of quality of South Chicago Illinois healthcare and patient safety. Two hundred hospitals including Riverside are participating in the “Raising the Bar” initiative to make Illinois a national leader in healthcare. 

Riverside leaders pledged to share best practices through the IHA Quality Care Institute. The pledge includes implementing innovative methods to prevent and reduce infections and other complications leading to unnecessary hospital re-admissions. Riverside signed the Raising the Bar: A Call to Action pledge, proving this Kankakee County hospital is dedicated to patient safety and success.

Phil Kambic, President and CEO of Riverside, stated, “Our signature on the pledge is further evidence of Riverside’s everyday mission to provide remarkable, quality healthcare experience to every one of our patients and their families. Riverside is continually recognized as a leader in patient care and safety. And the standards we subscribe to make that possible.”

Over the next three years, Illinois hospitals will be “Raising the Bar” on current standards. Hospitals joining the pledge must reduce re-admissions and infections acquired in hospitals along with other complications. Riverside and other Illinois hospitals are “Raising the Bar” to develop and implement key programs to achieve these goals. 

The “Raising the Bar” initiative seeks to help hospitals improve quality in major areas such as lowering 30-day hospital readmission rates for pneumonia, heart attack and congestive heart failure and minimizing infections and conditions acquired in hospitals such as surgical-site infections, C. difficile, Methicillin-resistant Staphylococcus aureus (MRSA), catheter-associated urinary tract infections (CAUTI), central-line associated bloodstream infections and pulmonary embolism and deep vein thrombosis following select orthopedic procedures.

By working through IHA’s Quality Care Institute, Riverside has access to tools, best practices and essential data from across the state as well as from state and national experts. These facilities help the Southern Chicago suburbs hospital offer better quality and improve patient safety through developing practical approaches for improving patient care and active advocacy to coordinate care.

To find out more about how Riverside Medical Center is “Raising the Bar,” visit www.RiversideMC.net. To learn more about IHA and the Quality Care Institute, visit www.illinoishospitals.org.

Media Contact:
Carl Maronich
815-935-7256
Email Contact

Click here to see all recent news from this company

Filed Under: Medical And Healthcare

Spina Bifida Association Launches New Program and Asks You to Educate Yourself and Loved Ones During Spina Bifida Awareness Month

Posted on October 5, 2010 Written by Annalyn Frame

SOURCE: Spina Bifida Association

Through Education SBA Hopes to Help More Families Learn About the Birth Defect

WASHINGTON, DC–(Marketwire – October 5, 2010) –  Did you know that birth defects occur in 7 out of every 10,000 live births in the U.S.? And Spina Bifida is the most common permanently disabling birth defect? In honor of October being Spina Bifida Awareness Month, the Spina Bifida Association is asking folks to take a few minutes today and get involved in the awareness month by educating loved ones.

The first question many have: What exactly is Spina Bifida? In short, Spina Bifida happens when the spinal column doesn’t close completely.

And how many births each day are affected? Well, it’s hard to believe, but eight births each day are affected by Spina Bifida or a similar birth defect of the brain and spine. If you think about it, there are currently over 65 million women in the U.S. who could become pregnant and each one of these ladies is at risk of having a baby born with Spina Bifida. So because Spina Bifida occurs during the first month of pregnancy (that’s even before most women know they’re pregnant!) it is that much more important to take proper precautions to help try to prevent it now. 

Okay. So what type of precautions can help in prevention, you may wonder?  
Although at this time there is no known cause of Spina Bifida, research has shown that if a woman takes 400 mcg of folic acid every day and before she becomes pregnant, she reduces her risk of having a baby with Spina Bifida or another neural tube defect by as much as 70%! That fact is reason enough to encourage women (and men) to get out there this month and spread awareness.

Families with a history of Spina Bifida should take extra dosages of folic acid prior to pregnancy. Hear one mom’s message: http://www.youtube.com/watch?v=qshRfegnGD4

And in honor of October’s Spina Bifida Awareness Month, SBA will also be launching some great new online resources, including:

  1. SB University (SBU) (www.sbuniversity.org), a new online educational program featuring taped sessions from the 2010 National Conference as well as monthly live seminars conducted by Spina Bifida medical professionals from around the country. During Awareness Month, SBU will debut new sessions each Monday.
  1. SBTween2Teen (www.sbtween2teen.org) a new Web site for tweens and teens with Spina Bifida. Complete with blogs, videos, real stories, fact sheets, and an Ask the Expert feature, the interactive site helps tweens and teens navigate the difficult road to adulthood. There is even a social networking component run through Facebook, allowing tweens and teens to interact with one another and build peer-to-peer relationships!
  1. Preparations, a new transition-focused Web site launching in late October allowing parents, caregivers, and clinicians to answer specific questions with regard to a child’s developmental milestones. This tool can even help young adults remedy some transitional challenges.

For even more information, tips and resource, you may visit: www.spinabifidaassociation.org
And be sure to join the Spina Bifida Association on Facebook: www.facebook.com/spina.bifida.learn

The Spina Bifida Association (SBA) serves adults and children who live with the challenges of Spina Bifida. Since 1973, SBA has been the only national voluntary health agency solely dedicated to enhancing the lives of those with Spina Bifida and those whose lives are touched by this challenging birth defect. Its tools are education, advocacy, research, and service. Through its network of chapters, SBA has a presence in more than 125 communities nationwide and touches thousands of people each year. For more information visit: www.spinabifidaassociation.org.

Media Contact
Amanda Darnley
[email protected]
800.621.3141 ext.15

id=”nav_links”>

Filed Under: Medical And Healthcare

CareCloud Raises $5 Million in Second Angel Investor Round

Posted on October 5, 2010 Written by Annalyn Frame

SOURCE: CareCloud

MIAMI, FL–(Marketwire – October 5, 2010) –  CareCloud, a provider of on-demand software and services for the healthcare industry, today announced it has closed a $5 million round of investment capital. Investors include a cadre of prominent entrepreneurs and business leaders. The Company has raised in excess of $7.8 million to date.

“We are delighted with the outpouring of support from our investors. They share our passion and vision to revolutionize the healthcare experience with our digital ecosystem,” said CareCloud President and CEO, Albert Santalo. “This funding is validation of the tremendous progress the company has made since closing its first round in January of 2010. We are experiencing explosive growth since our product launch in March of 2010, and we plan to use this capital to invest in our software development and service infrastructure while fueling additional growth.”

CareCloud offers a suite of web-based apps that allow physicians to manage their business and also allows them and their patients to communicate and collaborate with each other in real time across multiple points of care via the company’s web-based digital ecosystem. By leveraging the power of cloud computing to deliver technology-enabled services to healthcare providers, CareCloud is creating an integrated environment where all participants share a common commitment to reducing inefficiency and providing excellence in care.

CareCloud received global attention recently for winning top honors at IBM’s SmartCamp competition, an exclusive mentoring program through which IBM seeks to identify and support innovative new technology companies. As the winner of the Silicon Valley SmartCamp event, CareCloud will be competing against other winners from around the globe for the title of “World’s Smartest Startup,” as well as for the attention of many of the world’s most prominent venture capitalists.

About CareCloud
CareCloud is a web-based software and services company that modernizes the workflow in a medical practice. Visit CareCloud online at www.carecloud.com, blog.carecloud.com, or www.twitter.com/carecloud.

Media Inquiries
Mike Cuesta
Director of Marketing
CareCloud
305-265-4230
Email Contact

Click here to see all recent news from this company

Filed Under: Medical And Healthcare

Imaging3 Executes Securities Purchase Agreement for Sale of Common Stock and Warrants for $1 Million

Posted on October 5, 2010 Written by Annalyn Frame

SOURCE: Imaging3, Inc.

BURBANK, CA–(Marketwire – October 5, 2010) –  Imaging3™, Inc. (OTCBB: IMGG), developer of a breakthrough medical imaging device that produces 3D medical diagnostic images of virtually any part of the human body in real-time, announced today that the company entered into a Securities Purchase Agreement with two institutional investors for the sale of common stock and warrants for $1 million.

The terms of the securities purchase agreement include the sale of 4,587,157 shares of common stock at 20% discount to Friday’s closing price ($0.218). The warrants include: (i) Series A Warrants, which are immediately exercisable for a period of 5 years into 4,587,157 shares at $0.2725 per share; (ii) Series B Warrants, which are immediately exercisable for a period of up to 18 months into 4,587,157 shares at $0.218 per share and (iii) Series C Warrants, which are immediately exercisable for a period of 5 years into 4,587,157 shares at $0.2725 per share but only to the extent that the Series B Warrants are exercised and only in the same percentage that the Series B Warrants are exercised. All of such warrants contain customary adjustments for corporate events such as reorganizations, splits, dividends, and the exercise prices of all such warrants are subject to full-ratchet anti-dilution adjustments in the event of additional issuances of common stock below the exercise price then in effect.

“This transaction will provide Imaging3 with sufficient working capital for the next year,” stated the company’s Chairman/CEO Dean Janes.

The completion of the offering is subject to the satisfaction of customary closing conditions and is expected to close on or before October 14, 2010. The net proceeds from this offering will be used solely for working capital purposes. In the securities purchase agreement, the company agreed not to use the proceeds to satisfy any debt, to redeem any of the company’s outstanding securities or with respect to any litigation involving the company.

The company will also provide customary resale registration rights in connection with the offering.

Wharton Capital Partners, Ltd., a New York based investment banking firm, acted as the placement agent for the company in this offering.

The shares of common stock and warrants being sold in the placement have not been registered under the Securities Act and may not be offered or sold without registration with the Securities and Exchange Commission, or under an applicable exemption.

About Imaging3

Imaging3, Inc., founded in 1993, is a leading provider of advanced technology medical imaging devices. The Company has developed a breakthrough medical imaging device that produces 3D medical diagnostic images of virtually any part of the human body in real-time. Because these 3D images are instantly constructed in real-time, they can be used for any current or new medical procedures in which multiple frames of reference are required to perform medical procedures on or in the human body. Visit the company’s website at http://www.imaging3.com for more information.

Safe Harbor Statement

Matters discussed in this press release contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. When used in this press release, the words “anticipate,” “believe,” “estimate,” “may,” “intend,” “expect” and similar expressions identify such forward-looking statements. Actual results, performance or achievements could differ materially from those contemplated, expressed or implied by the forward-looking statements contained herein. These forward-looking statements are based largely on the expectations of the Company and are subject to a number of risks and uncertainties. These include, but are not limited to, risks and uncertainties associated with: the impact of economic, competitive and other factors affecting the Company and its operations, markets, product, and distributor performance, technological obsolescence, competition from other medical instrument(s) and imaging companies, lack of capital, unexpected costs, failure or delay of FDA approval, absence of revenue, the impact on the national and local economies resulting from an economic recession or terrorist actions, and U.S. actions subsequently; unavailability of financing for the Company or its customers, product malfunction and potential product liability claims, and other factors detailed in reports filed by the Company.

Contact:
Imaging3, Inc.
Investor Relations
800-900-9729

Filed Under: Facilities And Providers

Healthcare Information Solution Provider Enclarity Hires Chief Financial Officer

Posted on October 5, 2010 Written by Annalyn Frame

SOURCE: Enclarity, Inc.

Warren Gouk to Lead Business Development for Further Expansion Into Healthcare and Information Service Marketplaces and Cultivate Relationships for Strategic Partnership Building

ALISO VIEJO, CA–(Marketwire – October 5, 2010) – Enclarity, Inc., a leading healthcare information solutions company, today announced the appointment of Warren Gouk as chief financial officer and head of business development. Gouk will oversee all of the company’s financial strategy, financial reporting, along with leading the company’s business and corporate development efforts. He joins Enclarity from Cascadia Capital, where he served as managing director and practice leader across various teams within the company’s investment banking practice.

“This has been a year of tremendous expansion for Enclarity, which included financial investments, strategic partnerships, significant new clients and industry recognition, and we foresee this growth accelerating,” said Sean Downs, chief executive officer, Enclarity. “By bringing Warren on board, we now have the expertise in place to help guide Enclarity into the next phase of development. His extensive experience building strategic relationships will help us both build and maintain partnerships with companies like Emdeon, along with expanding our focus into other healthcare and information service markets.”

At Cascadia Capital, Gouk built the firm’s physical security and Internet digital media teams into a top-three nationally ranked investment banking practice. He has spent his career advising private and public high-growth companies in the healthcare technology and data services markets. In addition, Gouk worked for five years with PricewaterhouseCoopers as a financial auditor to middle market companies across North America and as a strategic advisor to governments in Central America and the Caribbean pursuing privatizations and project finance transactions. Gouk holds a finance degree from the University of British Columbia, and has earned the Chartered Accountant (CA) and Chartered Financial Analyst (CFA) designations.

About Enclarity
Enclarity® solves healthcare’s provider information problem. The company delivers correct, current and comprehensive provider information solutions by blending thousands of data sources, advanced analytics and healthcare expertise. As a result, its clients improve results in many areas, including claims processing, provider directories, regulatory compliance and market analysis. Named one of the Top 100 private technology companies in North America by Red Herring magazine and awarded the Global Healthcare Information Technology Excellence Award by Frost & Sullivan, Enclarity is headquartered in Aliso Viejo, Calif. For more information, visit www.enclarity.com.

Contacts

Company:
Brian Teeter
Enclarity, Inc.
949-614-8115
Email Contact

Media:
Theresa Dreike
Remarx Media Inc.
714-706-0433 ext. 102
Email Contact

Click here to see all recent news from this company

Filed Under: Facilities And Providers

FireHost Captures Managed Hosting Market for Healthcare Organizations; Major Academic Medical Centers Select FireHost as Secure Hosting Partner

Posted on October 5, 2010 Written by Annalyn Frame

SOURCE: FireHost, Inc.

FireHost Will Protect the Universities’ Critical Medical Websites and Applications

DALLAS, TX–(Marketwire – October 5, 2010) – The Biostatistics Center at Johns Hopkins University and the Department of Surgery at Duke University School of Medicine have selected FireHost, the leading secure, managed hosting provider, as their official Web host for special projects within their health care divisions. The websites and applications that FireHost will protect contain critical, confidential patient and research data that must remain secure.

Both Universities selected FireHost after conducting rigorous searches for a secure hosting provider that could achieve and maintain HIPAA (Health Insurance Portability and Accountability Act) requirements. Multiple layers of prevention protect every client within FireHost’s network, and the Web host is well versed in the additional precautions necessary to protect healthcare data for Duke and Johns Hopkins. Enterprise-grade Web hosting hardware including application level firewalls and DoS/DDoS mitigation devices are key components in providing a safe, HIPAA compliant-ready hosting environment for the Universities’ critical data.

“Medical organizations realize a high probability for cybercrime exists, and they must take every precaution possible to prevent a data breach. FireHost has built a reputation among healthcare organizations for protecting sensitive information online,” said Chris Drake, founder and CEO of FireHost. “We make it our priority to ward off vulnerabilities so Duke, Johns Hopkins, and all of our clients in healthcare can focus on what they do best, providing sophisticated research and patient care.”

Duke’s Center for Metabolic and Weight Loss Surgery has a Web application that stores patient data used to aid in the management and care throughout the program. James Alexander, systems analyst with the Duke Center for Metabolic and Weight Loss Surgery affirms, “There has never been a point in time in the field of healthcare service delivery that protection of patient information and privacy has been more important. Continually reviewing all of our systems and protections to make sure that we are well protected is yet another illustration of our primary commitment to our patients.”

The Biostatistics Center at the Johns Hopkins Bloomberg School of Public Health was looking for secure hosting for their Web-based data collection application. The application collects health research data that requires a high level of security and scalability, and FireHost was the clear choice. “We evaluated many providers and FireHost was our top choice to meet our secure hosting needs,” says Andre Hackman, faculty research associate of the Biostatistics Center. “Their support is the best we’ve ever worked with and the levels of security that they provide are unsurpassed. We have a great relationship with FireHost and I don’t hesitate to recommend FireHost to colleagues that are looking for secure hosting.”

FireHost has grown 150 percent in the first three quarters of 2010, and counts healthcare IT as one of its fastest growing segments along with Ecommerce and security companies. FireHost is an attractive, affordable alternative to traditional dedicated hosting. Medical SaaS providers and other professional services organizations that specialize in services that collect, store, and access protected patient information online have found the price, scalability, and protection they need with FireHost.

About FireHost, Inc.
FireHost, Inc. is a Dallas, Texas-based secure managed hosting company that delivers enterprise-quality hosting solutions. Specializing in protecting Web sites with compliance and high traffic needs, FireHost makes hacker prevention a standard part of every hosting plan. Advanced security combined with a comprehensive portfolio of hosting solutions helps FireHost protect companies of all sizes from threats to their Web sites, Web applications, and other valuable data.

Helpful links:
www.firehost.com
www.fireblog.com
Twitter.com/firehost

Contact:
Aly Saxe
Ubiquity Public Relations
Email Contact
602.268.6849

Click here to see all recent news from this company

Filed Under: Facilities And Providers

Detroit Dentist, Bright Side Dental, Offer Scholarships to Deserving Michigan Students

Posted on October 5, 2010 Written by Annalyn Frame

SOURCE: Bright Side Dental

A Local Michigan Dentist Gives Back to the Student Community by Helping Out With College Expenses

ROYAL OAK, MI–(Marketwire – October 5, 2010) –  Bright Side Dental, a local Detroit dentist, has established the Bright Future Scholarship Program to assist deserving local high school students in obtaining a college education. Applicants must be a graduating senior with a 3.0 cumulative grade point average or higher and be involved in extracurricular activities. Qualified applicants will live within Bright Side Dental service areas of Sterling Heights, Royal Oak, Livonia, and Canton, Michigan.

“We understand the importance of education and giving back to the community, and we are proud to offer the Bright Future Scholarship to deserving students,” said Josh Gershonowicz, Vice President of Public Relations & Marketing for Bright Side Dental.

Each applicant is required to complete a one page essay in response to the topic: Explain the importance of maintaining good dental hygiene and how poor dental hygiene can affect your overall health.

Essays will be judged by a panel of dental health experts and two students will be selected to receive a $500 scholarship that can be used toward college expenses. Student’s essays must be submitted by April 15th, 2011.

For more information and for how to apply, contact your local Bright Side Dental office or visit us online at http://www.brightsidedental.com/about-us/bright-future-scholarship/

About Bright Side Dental

Bright Side Dental is a member of the American Dental Association, Michigan Dental Association and Special Care Dentistry Association and offers a full array of dental, cosmetic and orthodontic services.

For more information about Bright Side Dental or to schedule an appointment, visit our website at www.BrightSideDental.com or call us at 1-800-PAINLESS.

Contact:
Tatum Rucker
Public Relations Assistant
Bright Side Dental
(248)629-1821

Click here to see all recent news from this company

Filed Under: Facilities And Providers

Mirada Medical Announces the Release of its Advanced XD3 PET-CT and Fusion Package on Sectra PACS

Posted on October 5, 2010 Written by Annalyn Frame

SOURCE: Mirada Medical

OXFORD, UK–(Marketwire – October 5, 2010) –

Mirada Medical Limited
(“Mirada” or “the Company”)

Mirada Medical Announces the Release of its Advanced XD3 PET-CT and Fusion Package on Sectra PACS

Oxford, UK and Pennsylvania, US, 5 October 2010: Mirada Medical Limited, the fast growing international company focused on advanced oncology imaging, announced today that its latest XD3 multi-modality image fusion analysis package is now available as an option to users of Sectra PACS. 

The latest version of Mirada XD3 is now available fully integrated into the Sectra workflow. This delivers greatly improved levels of productivity to radiologists and other users of medical imaging who want to access the most advanced tools and products from one workstation and without having to copy large quantities of image data from one location to another.

Using XD3,Sectra users can now be offered advanced quantification of PET, CT, MRI and SPECT including SUV measurements and access to standard disease response protocols such as RECIST for CT and PERCIST for PET and PETCT. The Mirada software supports comparison of two or more PET/CTs and also allows users to fuse MRI with PET, SPECT or CT. Mirada’s XD3 application also incorporates the latest versions of Mirada’s leading deformable image registration algorithms, which allow any combination of image modalities to be registered non-rigidly allowing for corrections to be made where patient positioning is inconsistent, or patient anatomy has changed over time.

Commenting on the new product release, Hugh Bettesworth, CEO of Mirada Medical, said: “It is central to Mirada’s philosophy that we make the advanced technologies available to the widest range of clinical users. By tightly integrating our XD3 application on Sectra PACS, users of this system can experience what we believe are the leading multi-modality workflows in the world, and do so in a way that can significantly boost productivity allowing more scans to be accurately analysed and reported.”

Commenting for Sectra, Per Elmhester, Product Manager Clinical Solutions said: “Sectra strives to constantly improve the offering to our customers. With this release our customers can now fully enjoy the benefits of the Mirada XD3-package.”

About Mirada Medical

Mirada Medical Limited develops internationally recognised medical imaging analysis applications that provide clinicians with advanced software applications for the quantification of images which are typically used in cancer diagnosis and treatment response assessment. Mirada Medical’s technology has broad applicability across nuclear medicine, diagnostic radiology, radiation oncology and medical oncology. Mirada Medical also markets products in neurology and cardiology. Mirada specialises in offering comprehensive and quantifiable analysis for the diagnosis, staging, treatment planning and assessment of treatment response in oncology. Mirada’s advanced technology allows medical images acquired using MRI, CT, SPECT or PET scanners to be combined into one, a process known as image fusion. Image fusion is useful in clinical interpretation as it allows different qualities of information to be combined into a single picture, for example, functional information such as metabolic activity, to be combined with anatomical information showing the precise location of pathology relative to bones and organs. This provides clinical users with a more complete picture, thereby improving the quality of information available when managing a patient’s condition. Mirada’s products are designed to support the comparison of multi-modal images acquired over any number of follow up visits by the patient, making them particularly well suited to the analysis of treatment response in longer term treatment plans such as those typical when treating cancer.

Mirada Medical was formed out of Oxford University by Professor Sir Michael Brady, one of the world’s leading medical imaging scientists. The Company is ISO 13485 certified and its technology has been supplied globally to customers in countries including the US, Japan, and Europe since 2001. Mirada’s products are sold by Mirada but also by major healthcare players such as McKesson, Siemens, Sectra, Carestream and Vital Images.

The Mirada team is a combination of world class scientists and exceptional engineers sourced from both Oxford University and leading blue-chip companies. For more information about Mirada Medical, please visit www.mirada-medical.com.

About XD3

Mirada’s XD3 multi-modality clinical reading application empowers radiologists and oncologists with the image analysis they need to diagnose disease and assess follow up to treatment. XD3 combines powerful registration technologies with serial review of acquisitions acquired over time. Key product features include disease specific oncology workflows and fast, accurate and reproducible image quantification, Mirada’s world class image registration engine powers multi-modal fusion and registration across time. XD3 facilitates advanced clinical decision support and may be deployed on PACS, workstation or laptop, providing the most flexible workflow integration available anywhere. Mirada Medical continues to develop superior products to suit the needs of clinicians for reviewing images in diagnosing, staging and evaluating disease progression and response to therapy. Mirada’s XD3 product provides comprehensive levels of analytical power to the clinical user. Featuring powerful disease specific oncology workflows and fast, accurate and reproducible image quantification, XD3 facilitates advanced clinical decision support. XD3 may be deployed on PACS, home workstation or laptop, providing the most productive workflow integration available anywhere.

About the Sectra Group

Sectra successfully develops and sells cutting-edge products in the expansive niche segments of medical systems and secure communication systems. The company was founded in 1978 and has its roots in Linköping University in Sweden. Today, Sectra has offices in twelve countries and operates through partners worldwide. Sales in the 2009/2010 fiscal year totaled SEK 848 million. The Sectra share is quoted on the NASDAQ OMX Stockholm AB exchange. For more information, visit www.sectra.com.

About Sectra’s medical operations

Sectra develops and sells IT-systems and products for radiology, mammography and orthopedics. More than 1,100 hospitals, clinics and imaging centers worldwide use the systems daily, together performing over 52 million radiology examinations annually. This makes Sectra one of the world-leading companies within systems for handling digital radiology images. In Scandinavia, Sectra is the market leader with more than 50% of all film-free installations. Sectra’s systems have been installed in North America, Scandinavia and most major countries in Europe and the Far East.

http://hugin.info/143183/R/1448965/391019.pdf

For more information, please contact:
Mirada Medical
Europe:
Hugh Bettesworth
CEO
tel: +44 (0) 1865 811172
US:
Joan Washburn
tel: +1 865 696 7809

M:Communications
Mary-Jane Elliott
Emma Thompson
tel: +44 (0)20 7920 2345
[email protected]

Filed Under: Medical And Healthcare

REMINDER: Media Advisory: Suntron Grand Opening Event

Posted on October 5, 2010 Written by Annalyn Frame

SOURCE: Suntron Corporation

METHUEN, MA–(Marketwire – October 5, 2010) – A ribbon cutting event is occurring at Suntron Corporation’s new manufacturing facility. Join Ed Wheeler, CEO of Suntron; Lt. Governor Timothy P. Murray; Congresswomen Niki Tsongas; Mayor Manzi III and Jose Bevilacqua in the opening event at 1pm, facility tour to follow.

Date:         October 5, 2010        
                                     
Time:         1:00 p.m.              
                                     
Location:     Suntron Corporation    
              300 Griffin Brook Drive
              Methuen, MA 01844      

For more information please contact:
Jen Winters
Email Contact
888-520-3382

Filed Under: Medical And Healthcare

Presidiohealth Launches PerformCycle(TM), a New Full Cycle Mobile Patient-Management Solution for Healthcare Providers

Posted on October 4, 2010 Written by Annalyn Frame

SOURCE: Presidiohealth

Service Will Initially Focus on Pediatric Asthma Patients

SAN FRANCISCO, CA–(Marketwire – October 4, 2010) –  Presidiohealth, which offers real-time, mobile computing performance management solutions for healthcare providers, announced today the launch of PerformCycle™, a new patient care management tool that provides an interactive, measurable action plan for pediatric asthma patients.

Presidio is launching the core service this month in the Pediatric Emergency Department at California Pacific Medical Center in San Francisco. Daily monitoring of the child’s status, triggers, and medication use seeks to provide better quality care, reduce emergency visits and hospitalizations, and lower overall healthcare and social costs. The PerformCycle platform combines evidence-based care guidelines, the Asthma Action Plan, and post-care patient tracking (CareTracker) solutions to offer home monitoring of a child’s post-care progress and share direct patient feedback with healthcare providers in the emergency department and the pediatrics office. For patients whose parents don’t have smartphones, the basic service delivers daily monitoring and reminders via two way communication with text message and e-mail. For iPhone users, CareTracker integrates the free AsthmaMD™ app.

“We are proud to be part of the first wave of healthcare innovation that brings the patient into the middle of the care cycle,” said Presidiohealth founder and president Douglas Evans. “As an ER physician, I know firsthand why delivering high quality care demands an interaction between provider best practices, enhanced patient education, and ongoing patient engagement. By combining our PerformCycle solutions with the exploding marketplace of mobile apps, we expect to offer health care providers and their patient communities new tools for enhancing care quality and clinical outcomes.” 

“All signs indicate healthcare is at the beginning of a revolution, called mHealth,” said Peter Waegemann, CEO of Medical Records Institute. “Communication-enhanced healthcare is a major part of this development. As new disease management methods emerge that integrate continuous sensing of data, provider monitoring and patient reporting, quality of care will improve and healthcare costs will be lowered. This has been proven in diabetes and hypertension management, but applies equally to asthma management.”

PerformCycle will be available immediately to pediatric asthma patients at California Pacific Medical Center, and beyond CPMC later this year. It will eventually expand to other high-cost-burden diseases. Dr. Evans will present the PerformCycle pilot project on the “Tools for Care Management” panel at the Health 2.0 Conference in San Francisco on October 7 and 8, 2010.

About Presidiohealth
Presidiohealth was founded in 2004 with the primary mission of providing performance management solutions for healthcare providers. Using SaaS and cloud technologies, the company consolidates critical business information so clients can manage clinical and revenue performance in one system. In addition to PerformCycle, Presidio’s services include PerformPOS™, PerformMD™, and PerformRN™ solutions. For more information, visit www.presidiohealth.com.

Media Contact
Doug Evans
+1 415-259-7855
Email Contact

Click here to see all recent news from this company

Filed Under: Medical And Healthcare

Ziegler Announces Transaction Closing for Bronson Methodist Hospital

Posted on October 4, 2010 Written by Annalyn Frame

SOURCE: Ziegler

CHICAGO, IL–(Marketwire – October 4, 2010) –  Ziegler (PINKSHEETS: ZGCO), a specialty investment banking firm serving hospital and healthcare systems clients since 1928, announced the successful transaction closing for Bronson Methodist Hospital (Bronson). Bronson is a 405-licensed bed general acute care hospital located in Kalamazoo, Michigan; Bronson is a part of the Bronson Healthcare Group, Inc.

Ziegler has served as Bronson’s investment banker for over seven years. During the financial crisis of 2008, Ziegler worked diligently with Bronson to reduce the risk profile of its capital structure by removing counterparty risk to financial institutions and by reducing the risks associated with variable rate indebtedness. In early 2010, Ziegler presented the opportunity for Bronson to further reduce its balance sheet risk. The Series 2010 transaction included the conversion of the outstanding insured variable rate demand obligations to fixed-rate bonds totaling $75 million that carried Assured Guaranty insurance. By converting this series to fixed- rate bonds, Bronson was able to preserve the value of its bond insurance policy and minimize its capital costs. The second series, which totaled $114.26 million, was structured as unenhanced securities and carried an “A2” rating from Moody’s. In conjunction with the fixed-rate conversion, which reduced counterparty, basis, remarketing, and acceleration risks, Bronson terminated corresponding fixed-payer swaps to further reduce its balance sheet risk profile.

John Hanley, Ziegler’s newly promoted head of its healthcare practice, commented, “Bronson offers an excellent example of how Ziegler works with its clients to identify creative financing solutions that best meet their organization’s short- and long-term financial goals.”

For more information about Ziegler and this transaction, please visit us at www.Ziegler.com.

About Ziegler:
The Ziegler Companies, Inc. (PINKSHEETS: ZGCO) together with its affiliates (Ziegler) is a specialty investment bank with unique expertise in complex credit structures and advisory services. Nationally, Ziegler is ranked as one of the leading investment banking firms in its specialty sectors of healthcare, senior living, religion and education finance, as well as corporate finance and FHA/HUD. Headquartered in Chicago, IL with regional and branch offices throughout the U.S., Ziegler creates tailored financial solutions including bond financing, advisory, private placement, seed capital, M&A, risk and asset management. Ziegler serves institutional and individual investors through its wealth management and capital markets distribution channels.

Certain comments in this news release represent forward-looking statements made pursuant to the provisions of the Private Securities Litigation Reform Act of 1995. The forward-looking statements are subject to a number of risks and uncertainties, in particular, the overall financial health of the securities industry, the strength of the healthcare sector of the U.S. economy and the municipal securities marketplace, the ability of the Company to underwrite and distribute securities, the market value of mutual fund portfolios and separate account portfolios advised by the Company, the volume of sales by its retail brokers, the outcome of pending litigation, and the ability to attract and retain qualified employees.

Leslie Lynch
312 596 1630
Email Contact

Filed Under: Facilities And Providers

PacMed Clinic Off & Running With Versus Advantages RTLS

Posted on October 4, 2010 Written by Annalyn Frame

SOURCE: Versus Technology, Inc.

TRAVERSE CITY, MI–(Marketwire – October 4, 2010) –  Versus Technology, Inc. (PINKSHEETS: VSTI) is pleased to announce that another phenomenal customer, Pacific Medical Center (PacMed), is now realizing the benefits of the Versus Advantages™ Real-time Locating System (RTLS). In April, Canyon Park Clinic, PacMed’s newest multi-specialty clinic in Bothell, WA, implemented the Versus Advantages™ Clinic solution to reduce patient visit times and improve the overall patient experience.

Taking time in September to share the Advantages of RTLS in Clinical Environments at Microsoft’s Health Users Group Exchange 2010, Brett Daniel, MD, Medical Director at Canyon Park Clinic announced that not only did the clinic achieve its primary goal to reduce overall average patient visit times from 70 to 46 minutes, it also reduced phone calls, demonstrated outstanding patient satisfaction scores, and is expected to promote material revenues. An impressive success, especially considering the RTLS was implemented only six months ago when the clinic opened.

“We were, and continue to be, focused on customer service, and the patient is our customer,” explains Linda Eremic, Director of Primary Care Services for PacMed. “Per our experience as both consumers and patients, we know that it makes sense to ensure that the customer is never left needlessly waiting–not in a waiting room, not in an exam room, not on the phone and not for a return call. Versus helps us manage our time and our patients to ensure that we can deliver the customer service our patients expect and deserve.” 

With up to 110 personnel on site and 300 patients currently moving in and about the Canyon Park Clinic‘s 30,000 sq. ft. each day, the Versus’ RTLS was sure to deliver benefit just in communicating the locations of patients, staff and equipment. However, for Versus, providing location information is just a necessary stepping stone to true clinical automation. PacMed is experiencing increased efficiencies as a result of:

  1. Knowing patient status and room availability. (Communicated simultaneously to all care providers and updated automatically.)
  2. No longer “rooming” patients. (Patients self-room, similar to checking in at a hotel.)
  3. Reports to monitor Key Performance Indicators and measure results.
  4. Alerts to ensure that providers and MAs see the patient at the right time, with the right information.

Dr. Daniel notes, “Every decision we made when designing the new clinic was centered on improving the patient experience. With Versus, what we didn’t expect is how great an impact it would also have on staff. Our staff is more productive, less stressed and patients have greater access to all of us. On the technology side, even our upcoming EMR implementation will be made easier by virtue of having the RTLS. As we anticipate greater distribution of the Versus system, our clinic has really become a model for how to do it well.”

“We really appreciate when our clients are willing to discuss the advantages of RTLS,” says HT Snowday, Versus’ CTO. “PacMed is unique in that they understood from the start that implementing RTLS wasn’t about simply tracking assets or choosing the technology that was easiest to install. It’s about delivering real, transformational change to patients and those who deliver patient care. To do so, facilities have to look beyond the locating technology to determine whether the solution offers clinical-quality data and whether the vendor understands the locating metrics as they relate to healthcare.”

Dr. Daniel will be presenting Canyon Park Clinic’s use case and outcomes with RTLS through an AHA Solutions, Inc. webinar on Wednesday, October 6, 2010. Those interested in learning more may register here: AHA Signature Learning Series – Patient Flow. 

About Pacific Medical Centers
Pacific Medical Centers is a private not-for-profit, multi-specialty health-care network of 10 locations with 140 primary and specialty care providers. Its 10 locations are in Puget Sound neighborhoods in Beacon Hill, Bothell, downtown Seattle, Northgate, Federal Way, First Hill, Lynnwood, Northgate, Renton and Totem Lake. Pacific Medical Centers serves patients with commercial insurance, retired military and their families, family members of active-duty personnel, as well as the underserved in our community.

About Versus Technology, Inc.
Established in 1988, Versus Technology, Inc. specializes in real-time location systems (RTLS) for healthcare. Used for enterprise patient tracking, bed management, asset tracking, and nurse call automation, Versus Advantages™ improves patient flow and documentation of caregiver and patient interactions, while enhancing communication and efficiency. Exclusively endorsed by the American Hospital Association, the Versus Advantages infrared (IR) and Active RFID solution is responsible for clinical-grade location and automation at a number of hospitals, clinics and long-term care facilities worldwide. To learn more about Versus Technology, Inc. (PINKSHEETS: VSTI), our technology and client successes, visit www.versustech.com and take the Advantages Tour.

Safe Harbor Provision
This release may include forward-looking statements which “bespeak caution,” and which are subject to risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. The statements are made only as of the date of this release, and the Company undertakes no obligation to update them to reflect subsequent events or circumstances.

Media Contact:
Versus Technology, Inc.
Stephanie Bertschy
Director of Marketing
877.983.7787
Email Contact

Investor/Analyst Contact:
Versus Technology, Inc.
Joseph Winowiecki
Chief Financial Officer
231.946.5868
Email Contact

Click here to see all recent news from this company

Filed Under: Facilities And Providers

Three Clinics Achieve Certification as SHAPE/HeartHealth Centers of Excellence

Posted on October 4, 2010 Written by Annalyn Frame

SOURCE: SHAPE

Clinics in Virginia and Missouri Recognized for Efforts to Prevent First Heart Attacks

HOUSTON, TX–(Marketwire – October 4, 2010) – SHAPE, The Society for Heart Attack Prevention and Eradication (http://www.shapesociety.org), a nonprofit organization that promotes the early detection and treatment of heart attack risk in apparently healthy people, today announced three clinics have achieved certification as SHAPE/HeartHealth Centers of Excellence. The newly certified clinics are Bon Secours Reynolds Crossing Imaging Center in Richmond, Va., Bon Secours St. Francis Hospital in Midlothian, Va., and St. John’s Heart Institute in Springfield, Mo.

The SHAPE/HeartHealth Centers of Excellence initiative encourages best practices in heart attack screening. To be considered for SHAPE/HeartHealth Centers of Excellence certification, a clinic must be committed to improving patient outcomes through early detection and primary prevention of coronary artery disease (CAD). Unlike traditional cardiovascular clinics that are primarily focused on preventing a second heart attack, SHAPE/HeartHealth Centers of Excellence focus on the prevention of a first heart attack — especially in the vulnerable population, those at risk of a near future heart attack.

“We congratulate these clinics on helping to advance preventive cardiology through the responsible practice of cardiovascular screening,” said JoAnne Zawitoski, chairwoman of the SHAPE Board of Directors. “Through these SHAPE/HeartHealth Centers of Excellence we are making progress toward preventing and, ultimately, eradicating heart attacks, but we have a very long way to go.”

SHAPE/HeartHealth Centers of Excellence adhere to the First SHAPE Guideline for screening to identify hidden CAD in apparently healthy individuals. The First SHAPE Guideline established standards for the careful and responsible implementation of scientifically proven atherosclerosis tests to detect hidden plaque buildup in coronary and carotid arteries, and recommended the tests be incorporated into routine screening for at risk men and women as they age.

In addition to the newly certified clinics, other SHAPE/HeartHealth Centers of Excellence are located in Arizona, Florida and Pennsylvania.

The SHAPE/HeartHealth Centers of Excellence Program coincides with SHAPE Provider Certification. For more information about these certification programs for your practice or hospital, please contact Dr. Jeff Fine at (803) 360-4756 or [email protected].

About SHAPE

Based in Houston, the Society for Heart Attack Prevention and Eradication (SHAPE) is a non-profit organization that promotes education and research related to prevention, detection, and treatment of heart attacks. SHAPE is committed to raising public awareness about revolutionary discoveries that are opening exciting avenues to prevent heart attacks. SHAPE’s mission is to eradicate heart attacks in the 21st century. Additional information is available on the organization’s Web site at www.shapesociety.org.

Contact:
Daniel Keeney, APR
DPK Public Relations
832.467.2904
Email Contact

Click here to see all recent news from this company

Filed Under: Medical And Healthcare

Uni-Ter Wins Computer Sciences Corporation Innovation Award

Posted on October 4, 2010 Written by Annalyn Frame

SOURCE: Uni-Ter Underwriting Management Corporation

ATLANTA, GA–(Marketwire – October 4, 2010) –  Uni-Ter Underwriting Management Corporation (UUMC), builder and manager of Risk Retention Groups in the healthcare industry, won the Computer Sciences Corporation (CSC) award for innovation in the process of customizing the CSC RISKMASTER X policy administration and claims processing software to reduce UUMC operational costs and increase efficiency.

According to the award citation, “Integrating all facets of the business will improve continuity and structure within the organization. UUMC has used the expertise that CSC has earned through its 50 years of industry experience to evaluate its business practices and establish guidelines to ensure that day-to-day operations are handled consistently and adequately. As a result of this process, UUMC has determined that integrating additional CSC products may be desired to achieve the all-inclusive system that would set UUMC apart from its competitors. A second phase project plan has already been initiated.”

The award was presented at CSC’s annual Connect Conference held in Kissimmee, Fl. The conference was attended by some 1,500 representatives of companies that do business with CSC.

For more information, contact:
Mechlin Moore
MDM Communications
239-777-1595
Email Contact

Filed Under: Medical And Healthcare

Kauffman Foundation to Release a Host of Studies on Health Care Issues in the United States

Posted on October 4, 2010 Written by Annalyn Frame

SOURCE: Ewing Marion Kauffman Foundation

Papers Range From Recommendations for Accelerating Drug Development to an Analysis of a New Health Care Reform Provision

KANSAS CITY, MO–(Marketwire – October 4, 2010) –  The Ewing Marion Kauffman Foundation will release several studies over the next month on various aspects of health care. Topics range from a call for a personalized health manifesto to employer-based health insurance effects on business creation and an analysis of the costs and benefits of the health care reform bill’s expanded comparative effectiveness research. Highlights of these studies are outlined below. Please contact us if you are interested in specific reports or would like advance copies.

  • The Personalized Health Manifesto. Billed as “an old-fashioned call to arms and action plan for a new age of health care,” the paper says there is a “new urgency for scientists to work together to focus on the whole human organism… and for society to absorb and implement scientific discoveries.” The Manifesto is an outgrowth of a larger study, and it calls on the life science community, policymakers, patients and society at large to take a list of actions to accelerate a transformation to personalized health.
  • Is Employer-based Health Insurance a Barrier to Entrepreneurship? This study asks whether employer-based health insurance has a negative effect on business creation by causing “job lock” in which workers may be reluctant to risk health coverage by leaving their jobs to start a company. The study examines the issue from several demographic factors, including gender and age, and raises concerns about how the bundling of health insurance and employment impacts business creation.
  • Promoting Comparative Effectiveness Research. This study addresses how to make the new health care reform law’s expansion of the comparative effectiveness research (CER) work best or to cause the least amount of harm. CER is research that attempts to analyze which treatment options are more effective than others in terms of quality and cost. A major focus of this study is on market-oriented, patient-centered approaches for disseminating and implementing CER to enhance health outcomes efficiently while preserving patient choice.
  • The New Role of Academia in Drug Development. The process for taking scientific discoveries from university labs to the market is stagnant and faces many obstacles. This paper outlines observations presented at a recent town hall meeting held at the Kauffman Foundation and presents recommendations for policymakers and thought leaders on how new collaboration models will benefit cancer cures and treatments. More information on the town hall meeting can be found here.

About the Kauffman Foundation
The Ewing Marion Kauffman Foundation is a private nonpartisan foundation that works to harness the power of entrepreneurship and innovation to grow economies and improve human welfare. Through its research and other initiatives, the Kauffman Foundation aims to open young people’s eyes to the possibility of entrepreneurship, promote entrepreneurship education, raise awareness of entrepreneurship-friendly policies, and find alternative pathways for the commercialization of new knowledge and technologies. In addition, the Foundation focuses on initiatives in the Kansas City region to advance students’ math and science skills, and improve the educational achievement of urban students, including the Ewing Marion Kauffman School, a college preparatory charter school for middle and high school students set to open in 2011. Founded by late entrepreneur and philanthropist Ewing Marion Kauffman, the Foundation is based in Kansas City, Mo. and has approximately $2 billion in assets. For more information, visit www.kauffman.org, and follow the Foundation on Twitter at @kauffmanfdn and Facebook.

Contacts:
Martin Maisonpierre
Edelman
212-704-8111
[email protected]

Barbara Pruitt
Kauffman Foundation
816-932-1288
[email protected]

Click here to see all recent news from this company

Filed Under: Medical And Healthcare

MedEx, Inc. Announces Shareholder Update

Posted on October 4, 2010 Written by Annalyn Frame

SOURCE: MedEx, Inc.

LAS VEGAS, NV–(Marketwire – October 4, 2010) –  MedEx, Inc. (PINKSHEETS: MDXX) is pleased to announce a shareholder update in light of missing the date of the previously announced audit. Because of the unique position that MedEx is in with its clients, namely Medicare, Medicaid, Workman’s Compensation, and various Insurance companies, it was in a position to conduct an audit that includes the month of September, which allowed the company to complete its 3rd quarter numbers. The audit will be released as soon as it is verified and signed off by management and the accounting firm.

“With September being particularly strong, we are excited to be able to include these numbers in our audit,” said Mr. Paul Protzman, President of MedEx, Inc.

“We would like to thank all of our existing shareholders for their patience. It is our goal to be as transparent as possible and we look forward to completing this milestone of becoming a fully reporting company. The company is currently negotiating with a number of potential acquisitions and it is important that we are current with our financials to assist in a smooth transition as we look to continue to acquire companies that we feel bring synergies to our core goal. That is to consolidate a number of DMEs (durable medical equipment) companies that are all in good standing with Medicare, Medicaid, Workman’s Comp. etc. and any other like businesses.”

About MedEx, Inc.

MedEx, Inc. is a development stage Nevada-based medical support services company, which plans to grow through acquisitions of medical supply companies, medical technology companies, and assisted living and care facilities worldwide. For additional information, see www.medexsynergies.com.  

Safe Harbor Statement:

This release contains “forward-looking statement” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may,” “future,” “plan,” or “planned,” “will,” or “should,” “expected,” “anticipates,” “draft,” “eventually,” or “projected.” You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements.

Investor Contact:
MedEx, Inc.
1-800-869-1060

Filed Under: Medical And Healthcare

LIVESTRONG(R) patrocina el Día Mundial de Acción contra el Cáncer

Posted on October 2, 2010 Written by Annalyn Frame

SOURCE: LIVESTRONG

Los patrocinadores auspician más de 1.000 eventos en todo el mundo para crear mayor conciencia acerca del cáncer

AUSTIN, TX–(Marketwire – October 1, 2010) –
El sábado, 2 de octubre, se realizarán más de 1.000 eventos en todo el mundo para marcar el Día LIVESTRONG, el día mundial anual de acción para celebrar la sobrevivencia y los esfuerzos hacia un mundo sin cáncer.

El 2 de octubre también marca el décimo cuarto aniversario del diagnóstico de cáncer y el inicio de su vida como defensor del cáncer del LIVESTRONG fundador y presidente, sobreviviente de cáncer y campeón de ciclismo, Lance Armstrong.

“La lucha contra el cáncer no sucede en un laboratorio”, dijo Armstrong. “Se lleva a cabo en nuestros hogares y comunidades mientras las familias luchan por combatir esta enfermedad. Este año, el cáncer se proyecta como la principal causa de muerte, cobrando más de ocho millones de vidas. El Día LIVESTRONG, las comunidades en todo el mundo se unirán para apoyar a las personas que viven con cáncer y hacer un llamado de acción renovada de nuestros líderes para combatir esta crisis de salud mundial”.

Más de 1.000 eventos, desde paseos en bicicleta a iniciativas ?Use Amarillo”, a venta de pasteles y galletas horneadas y mucho más, tendrán lugar en los 50 estados de Estados Unidos y en 57 países el Día LIVESTRONG mientras las personas y las comunidades se mantienen unidas en solidaridad para crear mayor conciencia y recaudar fondos para la lucha contra el cáncer. Los eventos incluyen:

  • Una vigilia con barras luminosas en las escalinatas el Capitolio de Colorado en Denver donde los seguidores celebrarán la supervivencia y recordaran a sus seres queridos ya perdidos
  • Un evento de paseo en bicicleta y concienciación del cáncer en Boston donde los participantes pedalearán en pos de la lucha contra el cáncer
  • Un evento de ciclismo de 24 horas en Atlanta donde los ciclistas recaudarán fondos para programas e investigaciones de cáncer
  • Una fiesta para ver un partido de futbol de Texas/Oklahoma en la sede de LIVESTRONG en Austin donde el equipo de LIVESTRONG educará a la comunidad acerca de sus recursos
  • Un evento para crear mayor conciencia y de aprendizaje en una escuela primaria en Los Ángeles donde los niños escribirán con tiza en el parque de juegos y compartirán sus ideas sobre lo significa vivir fuerte

LIVESTRONG también se asoció con Nike para crear mayor conciencia acerca del cáncer en el juego de fútbol de Red River Rivalry en Dallas entre The University of Texas en Austin versus The University of Oklahoma. Los aficionados realizarán una cartomagia centrada en el cáncer patrocinada por Nike durante el juego. La cartomagia creará una experiencia memorable para los aficionados y ayudarán a unirlos en la lucha contra el cáncer.

LIVESTRONG y RadioShack crean aún mayor conciencia sobre el cáncer el Día LIVESTRONG reclutando la ayuda de los defensores a través de Facebook y Twitter. El 2 de octubre, por cada persona que añada el número “28” a sus fotos de perfil en Facebook y Twitter para apoyar a los 28 millones de sobrevivientes de cáncer en todo el mundo, RadioShack donará $1 a LIVESTRONG hasta $100,000.

RadioShack también revelará una versión digital gigante del “Mosaico Equipo 28” en Times Square de Nueva York el Día LIVESTRONG por un solo día. El mosaico se basa en la fotografía icónica de Lance tomada en la etapa final de su Gira por Francia en 2010. El Mosaico Equipo 28 está compuesto por fotos de todos los seguidores de Facebook y Twitter que marcaron sus fotos de perfil con el símbolo del Equipo 28 (ver #team28 o http://twb.ly/team-28 vía Twitter). El vídeo de la pancarta de Military Island de Times Square se transmitirá en vivo online durante el día en http://team28.RadioShack.com, permitiendo que los seguidores vean sus imágenes de perfil agrandadas en el mosaico digital mientras las añaden.

También se motiva a los seguidores que usen Amarillo, el símbolo universalmente reconocido de la lucha contra el cáncer, Lance el Día LIVESTRONG se unirá en un testimonio mundial de fortaleza y coraje y demostrará su apoyo a los sobrevivientes de cáncer en todo el mundo. Más de 7.000 personas ya se han comprometido a usar Amarillo el Día LIVESTRONG.

El impacto del cáncer en todo el mundo aumenta todos los días. La American Cancer Society y LIVESTRONG recientemente unieron fuerzas para divulgar el primer estudio único en su tipo sobre el costo económico de todas las causas de muerte en el mundo, incluyendo el cáncer y otras enfermedades no contagiosas y contagiosas. Los datos de este estudio revelaron que el cáncer tiene el impacto económico más devastador que cualquier otra causa de muerte en el mundo, con un costo para la economía mundial de cerca de un billón de dólares al año.

El Día LIVESTRONG es una oportunidad para las personas de todo estrato social para luchar por el objetivo en común de asegurar que los sobrevivientes de cáncer en todo el mundo tengan la información, los recursos y el apoyo que necesitan para vivir con fortaleza y dignidad.

“Hoy tenemos una poderosa oportunidad para cambiar la manera en que las personas piensan acerca del cáncer”, dijo Doug Ulman, presidente y CEO de LIVESTRONG . “Toda persona que se une en la lucha contra el cáncer nos acerca hacia nuestro objetivo de un mundo libre de la enfermedad”.

To learn more, visit www.LIVESTRONG.org.

Acerca de LIVESTRONG
LIVESTRONG, fundada en 1997 por el sobreviviente de cáncer y campeón de ciclismo Lance Armstrong y centralizada en Austin, Texas, lucha por los 28 millones de personas en todo el mundo que viven con cáncer hoy en día. LIVESTRONG conecta a las personas con el apoyo que necesitan, utiliza fondos y recursos para estimular la innovación y compromete a las comunidades y líderes para impulsar un cambio social. Conocida por su icónica banda amarilla, la misión de LIVESTRONG es inspirar y empoderar a cualquier persona afectada por el cáncer.

Filed Under: Medical And Healthcare

LIVESTRONG(R) patrocina Dia Global de Ação contra o Câncer

Posted on October 1, 2010 Written by Annalyn Frame

SOURCE: LIVESTRONG

Partidários apresentam mais de 1.000 eventos em todo o mundo para disseminar a informação sobre o câncer

AUSTIN, TX–(Marketwire – October 1, 2010) –
Sábado, dia 2 de outubro, mais de 1.000 eventos em todo o mundo serão realizados para marcar o Dia LIVESTRONG, o dia anual mundial de ação para comemorar a sobrevivência e trabalho em prol de um mundo sem câncer.

O dia 2 de outubro também é o aniversário de 14 anos do diagnóstico e câncer do sobrevivente de câncer e ciclista camprão Lance Armstrong, fundador e chairman do LIVESTRONG e do início da sua vida como lutador contra o câncer.

“A luta contra o câncer não acontece em um laboratório”, disse Armstrong. “Ela acontece nas nossas casas e comunidades com a luta das famílias para vencer esta doença. Este ano, o câncer deve ser a principal causa de mortes, ceifando mais de oito milhões de vidas. No Dia LIVESTRONG, as comunidades de todo o mundo se unirão para dar suporte para quem vive com câncer pedindo ação renovada dos nossos líderes para o combate a esta crise de saúde mundial”.

Mais de 1.000 eventos — passeios de bicicleta, iniciativas “Wear Yellow” (usem amarelho), vendas de doces e outras — serão realizados nos 50 estados dos EUA e em 57 países no Dia LIVESTRONG com as pessoas e as comunidades se unindo em solidariedade para disseminar o conhecimento da luta contra o câncer. Os eventos são:

  • Uma vigília com uma haste brilhante nas escadas do Capitólio de Colorado em Denver para comemorar a sobrevivência e lembrar a perda de entes queridos.
  • Um passeio de bicicleta em grupo e um evento de informação sobre o câncer em Boston onde os participantes irão pedalar para lutar contra o câncer.
  • Um evento de ciclismo de 24 horas em Atlanta onde os ciclistas angariarão fundos para programas e pesquisa sobre o câncer.
  • Uma festa para assistir o jogo de futebol americano do Texas/Oklahoma na sede da LIVESTRONG em Austin onde a equipe da LIVESTRONG irá informar a comunidade sobre os seus recursos.
  • Um evento de aprendizado e disseminação de informação em uma escola de ensino fundamental em Los Angeles onde as crianças desenharão com giz no chão do playground e compartilhar suas ideias sobre o que elas acham ser ter uma vida forte.

LIVESTRONG também fez uma parceria com a Nike para disseminar o conhecimento do câncer em um jogo de futebol americano Red River Rivalry em Dallas da University of Texas at Austin e The University of Oklahoma. Os fãs farão uma apresentação com quadros sobre o câncer patrocinada pela Nike durante o jogo. A apresentação será uma experiência memorável para os fãs e irá ajudá-los na luta contra o câncer.

LIVESTRONG e RadioShack irão disseminar ainda mais o conhecimento sobre o câncer no Dia LIVESTRONG ao solicitar a ajuda de simpatizantes no Facebook e Twitter. No dia 2 de outubro, para cada pessoa que adicionar o número “28” nas fotos dos seus perfis no Facebook e Twitter em apoio aos 28 milhões de sobreviventes de câncer em todo o mundo, o RadioShack fará uma doaç ao de $1 dólar para LIVESTRONG com um máximo de $100.000,00.

RadioShack também fará uma apresentação digital do “Team 28 Mosaic” (Mosaico do número 28 da equipe) na Times Square de Nova York sobre o Dia LIVESTRONG apenas um dia. O mosaico está baseado na fotografia icônica de Lance tirada na etapa final da Tour de France de 2010. O Team 28 Mosaic é composto de fotos de todos os simpatizantes do Facebook e do Twitter que incluíram nas fotos do seu perfil o símbolo Team 28 (veja #team28 ou http://twb.ly/team-28 no Twitter). O vídeo do outdoor da Ilha Militar da Times Square será transmitido online ao vivo durante o dia no http://team28.RadioShack.com, para que os simpatizantes possam ver as imagens gigantescas dos perfis no mosaico digital à medida que são adicionadas.

Os simpatizantes também devem usar amarelho, o símbolo reconhecido mundialmente da luta contra o câncer, juntamente com Lance no Dia LIVESTRONG em uma demonstração mundial de força e coragem em apoio aos sobreviventes do câncer em todo o mundo. Mais de 7.000 pessoas já se comprometeram a usar amarelo no Dia LIVESTRONG.

O impacto do câncer em todo o mundo continua a aumentar diariamente. A American Cancer Society e LIVESTRONG recentemente se uniram para publicar o primeiro estudo sobre o custo econômico de todas as causas da morte no mundo, incluindo o câncer e outras doenças comunicáveis e não comunicáveis. Os dados deste estudo mostram que o câncer tem o impacto mais devastador do que qualquer causa de morte no mundo, custando quase três milhões de dólares ao ano para a economia global.

O Dia LIVESTRONG é uma oportunidade para as pessoas de todas as áreas trabalharem em prol de um objetivo comum de garantir que os sobrevivente do câncer de todo o mundo tenham acesso à informação, recursos e suporte necessários para que elas possam viver a vida com forá e dignidade.

“Hoje, temos a grande oportunidade de mudar a forma como as pessoas pensam sobre o câncer”, disse Doug Ulman, Presidente e CEO da LIVESTRONG. “Cada indivíduo que se úne à luta contra o câncer nos leva cada vez mais próximos ao nosso objetivo de um mundo sem esta doença”.

Para mais informações, acesse www.LIVESTRONG.org.

LIVESTRONG
Fundada em 1997 pelo sobrevivente de câncer e campeão de ciclismo Lance Armstrong e baseada em Austin, Texas, a LIVESTRONG luta pelas 28 milhões de pessoas que vivem com câncer no mundo todo hoje. A LIVESTRONG conecta indivíduos para atender suas necessidades, aproveitar os financiamentos e recursos para impulsionar a inovação e envolver as comunidades e líderes na mudança social. Conhecida por sua pulseira amarela icônica, a LIVESTRONG tem por missão inspirar e capacitar qualquer pessoa afetada pelo câncer.

Filed Under: Medical And Healthcare

Pulse Systems’ 2011 Pulse Complete EHR Receives ONC-ATCB 2011/2012 Certification

Posted on October 1, 2010 Written by Annalyn Frame

SOURCE: Pulse Systems, Inc.

WICHITA, KS–(Marketwire – October 1, 2010) –  Pulse Systems, Inc. announced today that 2011 Pulse Complete EHR, Version 2011, is 2011/2012 compliant and was certified as a Complete EHR on September 30, 2010 by the Certification Commission for Health Information Technology (CCHIT®), an ONC-ATCB, in accordance with the applicable eligible provider certification criteria adopted by the Secretary of Health and Human Services. The 2011/2012 criteria support the Stage 1 meaningful use measures required to qualify eligible providers and hospitals for funding under the American Recovery and Reinvestment Act (ARRA).

“I am certain our clients will be at the front of the line when the incentive payments begin in April 2011 — the first of five payments totaling up to $44,000. This is because our EHR product is in the first group to receive this landmark certification. This mirrors our industry-leading accomplishment in being the first to receive the full comprehensive CCHIT 2011 certification in December of 2009,” said Basil Hourani, President and CEO of Pulse Systems. 

“We built our EHR software with the capability to be used in a meaningful way to help our clients provide more efficient patient care before that concept was even legislated,” he said. “This foresight is the primary reason that we were able to receive certification so promptly.”

The ONC-ATCB 2011/2012 certification program tests and certifies that Complete EHRs meet all of the 2011/2012 criteria and EHR Modules meet one or more — but not all — of the criteria approved by the Secretary of Health and Human Services (HHS) for either eligible provider or hospital technology.

“CCHIT is pleased to be testing and certifying products so that companies are now able to offer these products to providers who wish to purchase and implement certified EHR technology and achieve meaningful use in time for the 2011-2012 incentives,” said Karen M. Bell, M.D., M.S.S., Chair, CCHIT.

2011/2012 certification conferred by CCHIT does not represent an endorsement of the certified EHR technology by the U.S. Department of Health and Human Services nor does it guarantee the receipt of incentive payments.

The clinical quality measures to which 2011 Pulse Complete EHR has been certified include:

2011 Pulse Complete EHR version 2011 is also certified in CCHIT’s separate and independently developed certification program. 2011 Pulse Complete EHR version 2011 is a CCHIT Certified® 2011 Ambulatory EHR, additionally certified for Child Health. Pulse Systems has certified its EHR technology in both programs to provide greater assurance to its customers.

About Pulse Systems, Inc.
Pulse offers Electronic Health Records (EHR), Practice Management, ePrescribing and Revenue Cycle Management (Billing Services) used nationwide in more than 26 medical specialties. Pulse Practice Management and EHR products have both earned five star ratings from AC Group. Since 1982 Pulse has developed, marketed and supported healthcare practice workflow solutions that are easier to purchase, implement, learn, utilize and upgrade. This focus on making things easier for clients is the key to a remarkable 95% client renewal rate. Pulse is a part of Cegedim Healthcare Software (CHS), a division of $1.1 billion global healthcare technology company Cegedim Group. For more information, please visit www.pulseinc.com.

About CCHIT
The Certification Commission for Health Information Technology (CCHIT®) is an independent, 501(c)3 nonprofit organization with the public mission of accelerating the adoption of robust, interoperable health information technology. The Commission has been certifying electronic health record technology since 2006 and is approved by the Office of the National Coordinator for Health Information Technology (ONC) of the U.S. Department of Health and Human Services (HHS) as an Authorized Testing and Certification Body (ONC-ATCB). More information on CCHIT, CCHIT Certified® products and ONC-ATCB certified electronic health record technology is available at http://cchit.org.

About ONC-ATCB 2011/2012 certification
The ONC-ATCB 2011/2012 certification program tests and certifies that EHR technology is capable of meeting the 2011/2012 criteria approved by the Secretary of Health and Human Services (HHS). The certifications include Complete EHRs, which meet all of the 2011/2012 criteria for either eligible provider or hospital technology and EHR Modules, which meet one or more — but not all — of the criteria. ONC-ATCB certification aligns with Health Information Technology: Initial Set of Standards, Implementation Specifications, and Certification Criteria for Electronic Health Record Technology published in the Federal Register in July 2010 and strictly adheres to the test procedures published by the National Institute of Standards and Technology (NIST) at the time of testing. ONC-ATCB 2011/2012 certification conferred by the Certification Commission for Health Information Technology (CCHIT®) does not represent an endorsement of the certified EHR technology by the U.S. Department of Health and Human Services nor does it guarantee the receipt of incentive payments.

“CCHIT®” and “CCHIT Certified®” are registered trademarks of the Certification Commission for Health Information Technology.

Media Contacts:
Bruce Rowley
Senior Vice President
[email protected]
(316) 636-5900 ext.1152

Click here to see all recent news from this company

Filed Under: Medical And Healthcare

Interim HealthCare Teams Up With ABC’s Extreme Makeover: Home Edition

Posted on October 1, 2010 Written by Annalyn Frame

SOURCE: Interim HealthCare

Healthcare Franchise Leader Provides Services to East Setauket, NY Family

SUNRISE, FL–(Marketwire – October 1, 2010) –  Interim HealthCare® Inc., the nation’s first and finest healthcare and in-home senior care franchise company, is donating in-home, non-medical care to the Lutz family of East Setauket, NY, in the Town of Brookhaven, as part of the October 3rd episode of ABC’s Emmy-winning hit show Extreme Makeover: Home Edition. The local Interim HealthCare in New York, owned and operated by Jim Watson, is providing the family’s six young adult children, all of whom have Down syndrome, with a staff member to assist with companionship and homemaker care. The in-kind donation totals 20 hours per week for a year.

“Interim HealthCare became aware of the needs of the Lutz family several months ago, and as an in-home care company specializing in services the Lutz family needed, we felt compelled to help,” said Jim Watson, owner of Interim HealthCare of Greater New York. “We know firsthand the struggles that families encounter when they are the primary caregivers for their relatives, and we knew Interim HealthCare could certainly be of assistance in this case.”

Unable to have any children of their own, Grace and John Lutz gave their hearts to 18 adopted children, including seven with Down syndrome. After the couple unexpectedly passed away, their daughter Kathleen, gladly gave up her career and came home to take care of her six Down syndrome siblings who currently range in age from 20 to 25 years old. Everyone agreed that putting the kids in a group home or institution was not an option. It was a good plan, until Kathleen unexpectedly had a grand mal seizure and was diagnosed with inoperable cancer. Her brother John Jr., was next to help, sacrificing his career as a gymnastics coach to move home and care for his sister and other siblings. Kathleen’s health is now stabilized and both brother and sister care for their family as a team.

For more information about Interim HealthCare in Stony Brook, NY please contact Ellen Hamburger, Branch Administer at 631-689-8920. The local office is open from 8:00 am – 5:00 pm Monday – Friday, and can be reached 24 hours a day, seven days a week.

About Interim HealthCare:
Founded in 1966, Interim HealthCare® is the nation’s oldest proprietary national health care franchise organization providing health care personnel at all skill levels in all settings. Through a comprehensive network of more than 300 independently owned franchise offices, Interim HealthCare® franchisees are the largest combined provider of community-based home care (skilled and non-medical) and health care staffing. Interim HealthCare is unique in combining the commitment of local ownership with the support of a national organization that develops innovative programs and quality standards that improve the delivery of service through franchisees who employ more than 75,000 health care workers who serve 50,000 people each day. For more information or to locate an Interim HealthCare office, visit www.interimhealthcare.com.

About Extreme Makeover: Home Edition
The Emmy award winning reality program “Extreme Makeover: Home Edition,” is entering its 7th season, is produced by Endemol USA, a division of Endemol Holding. It’s executive-produced by Brady Connell and George Verschoor. David Goldberg is Chairman, Endemol North America. The show airs Sundays from 8:00-9:00 p.m., ET on ABC.

Contact:
Carmen Ordonez
Fish Consulting
954.893.9150
[email protected]

Click here to see all recent news from this company

Filed Under: Medical And Healthcare

LIVESTRONG(R) Sponsors Global Day of Action Against Cancer

Posted on October 1, 2010 Written by Annalyn Frame

SOURCE: LIVESTRONG

Supporters Host More Than 1,000 Events Around the World to Raise Cancer Awareness

AUSTIN, TX–(Marketwire – October 1, 2010) –  On Saturday, October 2nd, more than 1,000 events throughout the world will take place to mark LIVESTRONG Day, the annual global day of action to celebrate survivorship and work toward a world without cancer.

October 2 also marks the 14th anniversary of LIVESTRONG founder and chairman, cancer survivor and champion cyclist Lance Armstrong’s cancer diagnosis and the beginning of his life as a cancer advocate.

“The fight against cancer doesn’t happen in a lab,” said Armstrong. “It takes place in our homes and communities as families struggle to beat this disease. This year, cancer is projected to become the world’s leading cause of death, claiming more than eight million lives. On LIVESTRONG Day, communities throughout the world will unite to support those living with cancer and call for renewed action by our leaders to combat this global health crisis.” 

More than 1,000 events — from bike rides and “Wear Yellow” initiatives, to bake sales and beyond — will take place in all 50 U.S. states and across 57 countries on LIVESTRONG Day as individuals and communities stand unified in solidarity to raise awareness and funds for the fight against cancer. Events include:

  • A glow stick vigil on the Colorado Capitol steps in Denver where supporters will celebrate survivorship and remember lost loved ones
  • A group bike ride and cancer awareness event in Boston where participants will pedal to fight cancer
  • A 24-hour cycling event in Atlanta where cyclists will raise funds for cancer programs and research
  • A Texas/Oklahoma football game watching party at LIVESTRONG headquarters in Austin where LIVESTRONG staff will educate the community about its resources
  • A learning and awareness building event at an elementary school in Los Angeles where children will chalk up the playground and share their ideas about what it means to live strong

LIVESTRONG has also partnered with Nike to raise cancer awareness at the Red River Rivalry football game in Dallas featuring The University of Texas at Austin versus The University of Oklahoma. Fans will perform a cancer-focused card stunt sponsored by Nike during the game. The stunt will create a memorable experience for fans and help unite them in the fight against cancer.

LIVESTRONG and RadioShack are further raising cancer awareness on LIVESTRONG Day by enlisting the help of supporters through Facebook and Twitter. On October 2, for every person who adds the number “28” to their Facebook and Twitter profile pictures to support the 28 million cancer survivors around the world, RadioShack will donate $1 to LIVESTRONG up to $100,000.

RadioShack will also unveil a giant digital rendition of the “Team 28 Mosaic” in New York’s Times Square on LIVESTRONG Day for one day only. The mosaic is based on the iconic photograph of Lance taken at the final stage of the 2010 Tour de France. The Team 28 Mosaic is comprised of photos of all the Facebook and Twitter supporters who have tagged their profile photos with the Team 28 symbol (see #team28 or http://twb.ly/team-28 via Twitter). Video of the billboard at Times Square’s Military Island will be streamed live online during the day at http://team28.RadioShack.com, allowing supporters to view larger-than-life profile images on the digital mosaic as they are added.

Supporters are also encouraged to wear yellow, the universally recognized symbol of the fight against cancer, with Lance on LIVESTRONG Day to join in a global statement of strength and courage and show support for cancer survivors around the world. More than 7,000 people have already committed to wearing yellow on LIVESTRONG Day.

The impact of cancer around the globe is growing every day. The American Cancer Society and LIVESTRONG recently joined together to release a first-of-its-kind study on the economic cost of all causes of death globally, including cancer and other noncommunicable diseases and communicable diseases. The data from this study revealed that cancer has the most devastating economic impact of any cause of death in the world, costing the global economy nearly a trillion dollars a year.

LIVESTRONG Day is an opportunity for people from all walks of life to work toward the common goal of ensuring that cancer survivors around the world have the information, resources and support they need to live with strength and dignity.

“Today we have a powerful opportunity to change the way people think about cancer,” said Doug Ulman, LIVESTRONG President and CEO. “Every single person who joins the fight against cancer brings us closer to our goal of a world free from the disease.”

To learn more, visit www.LIVESTRONG.org.

About LIVESTRONG
Founded in 1997 by cancer survivor and champion cyclist Lance Armstrong and based in Austin, Texas, LIVESTRONG fights for the 28 million people around the world living with cancer today. LIVESTRONG connects individuals to the support they need, leverages funding and resources to spur innovation and engages communities and leaders to drive social change. Known for the iconic yellow wristband, LIVESTRONG‘s mission is to inspire and empower anyone affected by cancer.

Contact:
Rae Bazzarre
(512) 279-8367
[email protected]

Filed Under: Medical And Healthcare

Dr. Gregory H. Dorn Named President of First DataBank

Posted on October 1, 2010 Written by Annalyn Frame

SOURCE: Hearst Corporation

NEW YORK, NY–(Marketwire – October 1, 2010) –  Hearst Corporation announced today that Gregory H. Dorn, MD, MPH, has been named president of First DataBank, a subsidiary of Hearst Business Media. Dorn succeeds Donald M. Nielsen, MD, who has been appointed chairman of the First DataBank Advisory Board and senior health advisor. The appointments were announced today by Frank A. Bennack, Jr., vice chairman and CEO of Hearst Corporation, and Richard P. Malloch, president of Hearst Business Media, and are effective immediately.

Most recently, Dorn was executive vice president of Zynx Health, another Hearst health-care property. In this management position, Dorn focused on point-of-care clinical decision support solutions. Zynx Health has grown under Hearst’s ownership to serve more than 1,700 hospitals in the U.S.

“Over the past six years, Greg has contributed to Zynx’s extraordinary success and expansion, which has resulted in revenue growth each year of about 70 percent,” Malloch said. “In the coming years, with the growing adoption of electronic health records and e-prescribing, we see First DataBank as well poised for significant growth, and Greg is the right leader to see that through.”

Dorn has numerous peer-reviewed publications and is co-author of a pending patent and a lecturer on quality improvement for the UCLA Center for Health Services Management. He has a bachelor’s degree from the Columbia University School of Engineering and received his medical doctorate from the College of Physicians and Surgeons at Columbia University. Dorn served as house officer at UCLA Medical Center after which he went on to obtain his master’s in health services from the UCLA Center for Health Services Management. Dorn will be based out of First DataBank’s offices in San Francisco.

In his new role as chairman of the First DataBank Advisory Board, Nielsen will focus on strengthening First DataBank’s long-standing commitment to patient safety and health-care data quality issues. Nielsen also will be working on initiatives related to drug reimbursement.

“Don has done an outstanding job driving First DataBank’s leadership position in patient safety and health care quality during the past four years,” Malloch said. “I’m thrilled to have Don now leading two very important areas at First DataBank. There is no one as well qualified as Don to advocate for quality in data and patient care and his extensive knowledge and understanding of drug reimbursement practices will be of great value to Hearst as a whole as we build out those areas of business.”

About First DataBank
First DataBank, a subsidiary of Hearst Corporation, drives patient safety and health care quality by providing drug databases that are used within information systems that touch every aspect of health care. For 30 years, First DataBank has partnered with system developers to integrate and optimize its drug information to improve user workflow and enhance clinical decision-making by those entrusted with treating patients at the point-of-need. Together with its development partners, First DataBank helps reduce the incidence of medication errors and adverse drug events, which promises to lower health-care costs and improve patient care. For more information about First DataBank, call 800-633-3453 or visit www.firstdatabank.com.

About Hearst Corporation
Hearst Corporation (www.hearst.com) is one of the nation’s largest diversified media companies. Its major interests include ownership of 15 daily and 38 weekly newspapers, including the Houston Chronicle, San Francisco Chronicle, San Antonio Express-News and Albany Times Union; nearly 200 magazines around the world, including Good Housekeeping, Cosmopolitan and O, The Oprah Magazine; 29 television stations, which reach a combined 18% of U.S. viewers; ownership in leading cable networks, including Lifetime, A&E, History and ESPN; as well as business publishing, including a minority joint venture interest in Fitch Ratings; Internet and marketing services businesses, television production, newspaper features distribution and real estate.

Contacts:
Paul J. Luthringer
212-649-2540
[email protected]

Lisa K. Bagley
212-649-2337
[email protected]

id=”nav_links”>

Filed Under: Medical And Healthcare

Forbes Magazine Names Dr. Tom Tooma Leading U.S. Laser Eye Surgeon

Posted on October 1, 2010 Written by Annalyn Frame

SOURCE: NVISION Laser Eye Centers

NEWPORT BEACH, CA–(Marketwire – October 1, 2010) –  NVISION Laser Eye Centers, formerly part of TLC Laser Eye Centers, announced today that Dr. Tom Tooma has been selected by Goldline Research as one of the leading Laser Eye Surgeons of the United States for 2010. The list of leading Laser Eye Surgeons of the United States was published this week in Forbes Magazine.

“It is a great honor to be selected by Goldline Research and to receive this distinction as one of only ten LASIK surgeons to be listed in Forbes Magazine in 2010,” said Dr. Tom Tooma, the Medical Director for NVISION Laser Eye Centers, formerly part of TLC Laser Eye Centers, and renowned eye surgeon who has performed more than 100,000 vision correction procedures.

“There are more than 10,000 laser eye surgeons in the United States. The practices that we selected provide outstanding patient care that exceeds the industry standard,” said Victoria Coryelle, Analyst, Goldline Research. “We believe that these practices are setting the benchmarks for patient service for the industry as a whole.”

Goldline Research, an independent, third-party research firm specializing in evaluating special services firms, undertook an extensive research process, including individual company interviews, qualitative analysis of company data and customer reference checks to determine high-quality patient care. Dr. Tom Tooma, NVISION Laser Eye Centers, was the only practice chosen in California due to his remarkable service and overall patient satisfaction in the industry.

About NVISION Laser Eye Centers
NVISION Laser Eye Centers, formerly part of TLC Laser Eye Centers, has eight locations throughout Southern California from San Diego to Camarillo. With more than 1,300 eye doctors who refer their patients and trust their own eyes to NVISION affiliate surgeons, we are the Eye Doctors’ #1 Choice, and serve the counties of San Diego, Los Angeles, Orange, Riverside, Ventura and San Bernardino. For more information, visit our new web site at www.NVISIONCenters.com or call 1-877-91NVISION (1-877-916-8474).

Contact:
Jennifer Heinly
J&J Consulting
949-716-9829 (w)
949-838-7335 (cell)
Email Contact

Click here to see all recent news from this company

Filed Under: Medical And Healthcare

New Mexico Scientific Laboratory Division Dedicates New State-of-the-Art Facility

Posted on October 1, 2010 Written by Annalyn Frame

SOURCE: Association of Public Health Laboratories

SILVER SPRING, MD–(Marketwire – October 1, 2010) –  The Association of Public Health Laboratories (APHL) is proud to announce the dedication of the new comprehensive New Mexico public health laboratory. On September 29, 2010, the New Mexico Scientific Laboratory Division dedicated their beautiful, state-of-the-art facility which will double their space and greatly expand testing capabilities.

“This new laboratory is the crown jewel of state government,” said Arturo L. Jaramillo, cabinet secretary of the New Mexico General Services Department.

A LEED-certified green facility, this cutting edge laboratory boasts accreditations by numerous agencies. For the first time, the New Mexico public health laboratory will have onsite training facilities. Agreements have already been finalized with the Centers for Disease Control and Prevention to do Laboratory Response Network (LRN) training, the Food and Drug Administration for their dairy analyst training, and the University of New Mexico law school to teach new judges the scientific methods of DWI testing.

“It takes a special laboratory to help shape the future — a specially equipped facility staffed with highly qualified and trained experts, one like the laboratory here,” said APHL’s Executive Director, Scott Becker who attended the dedication. “Who knows — this new space could uncover the clues of some of our most pressing public health issues.”

This year marks the 90th anniversary of the New Mexico public health laboratory. From its origin in 1920 with one visionary employee in a one-room facility, the new building will house state-of-the-art clinical, environmental and forensic analytical services in support of public health across the state and nation.

Press tours of the new public health laboratory will take place on Friday, October 1, 2010.

The Association of Public Health Laboratories is a national non-profit located in Silver Spring, MD, that is dedicated to working with members to strengthen governmental laboratories with a public health mandate. By promoting effective programs and public policy, APHL strives to provide public health laboratories with the resources and infrastructure needed to protect the health of US residents and to prevent and control disease globally.

Contact:
Michelle M. Forman
Senior Media Specialist
240.485.2793
Email Contact

Click here to see all recent news from this company

Filed Under: Medical And Healthcare

GlobeImmune Announces Late-Breaker Oral Presentation of GI-5005 Prior Non-Responder Data at AASLD 2010 Meeting

Posted on October 1, 2010 Written by Annalyn Frame

SOURCE: GlobeImmune, Inc.

Immunology Data Also to Be Presented in Poster Session

LOUISVILLE, CO–(Marketwire – October 1, 2010) –  GlobeImmune Inc. today announced that an abstract related to GI-5005, its Phase 2 investigational hepatitis C virus (HCV) product candidate, has been accepted for a late breaking oral presentation at the 61st Annual Meeting of the American Association for the Study of Liver Diseases (AASLD), which will take place October 29 through November 2, 2010, in Boston.

At the AASLD annual meeting, GlobeImmune will present end-of-study data, including sustained virologic response (SVR) rate from prior non-responders, from a Phase 2 clinical study investigating the safety and efficacy of GI-5005. The study compared GI-5005 plus peg-interferon (peg-IFN) and ribavirin, the current standard of care (SOC), versus SOC alone in patients with chronic type 1 hepatitis C infection. Prior non-responders were defined as those patients who did not achieve viral negativity by PCR after a minimum of 12 weeks of SOC. Patients that had achieved viral negativity by PCR during prior SOC but had relapsed during or after completion of SOC therapy were excluded from the study.

The abstract, titled “GI-5005 Therapeutic Vaccine Plus PEG-IFN/Ribavirin Improves Sustained Virologic Response Versus PEG-INF/Ribavirin in Prior Non-Responders With Genotype 1 Chronic HCV Infection,” is published online at the AASLD Web site.

Dr. Paul J. Pockros of Scripps Clinic is the lead author of the abstract that will be presented as part of a late breaker oral session beginning at 6 p.m. EDT on Monday, November 1, 2010 in the Hynes Auditorium. The presentation will include complete response and sustained virologic response rates for patients who received the GI-5005 plus SOC as well as SOC patients in the control arm of the study.

Additionally, Dr. John M. Vierling of Baylor College of Medicine will present a poster titled “GI-5005 Therapeutic Vaccine Improves Deficit in Cellular Immunity in IL28B Genotype T/T, Treatment-Naïve Patients with Chronic Hepatitis C Genotype 1 When Added to Standard of Care PEG-IFN-Alfa-2A/Ribavirin,” on Tuesday, November 2, 2010 in the Hynes Exhibit Hall C.

GI-5005 is a therapeutic vaccine candidate that the company believes generates HCV specific T-cell responses and improves virologic responses in patients with chronic hepatitis C infection. 

About GlobeImmune
GlobeImmune Inc. is a private company developing active immunotherapies called Tarmogens for the treatment of cancer and infectious diseases. Tarmogens generate activated killer T cells that are designed to locate and eliminate cancer cells and/or virally-infected cells. The Company’s lead product candidate, GI-5005, is a Tarmogen being developed for the treatment of chronic hepatitis C infection (HCV). GI-5005 is designed to complement both the current standard of care and emerging novel therapies for HCV. The Company’s lead oncology program, GI-4000, targets cancers caused by mutated versions of the Ras oncoprotein. GI-4000 is being investigated in clinical trials for the treatment of pancreas cancer as well as other cancers that contain mutated Ras, including non-small cell lung cancer and colorectal cancer. In May 2009, the Company announced a global partnership with Celgene focused on the discovery, development and commercialization of multiple product candidates for the treatment of cancer.

For additional information, please visit the company’s Web site at www.globeimmune.com.

This news release and the anticipated presentation contain forward-looking statements that involve risks and uncertainties, including statements relating to initiation and progress of the Company’s clinical trial programs and the results from the clinical trials. Actual results could differ materially from those projected and the Company cautions readers not to place undue reliance on the forward-looking statements contained in the release and anticipated presentation.

Filed Under: Medical And Healthcare

AdCare Health Systems Acquires Two Alabama Nursing Homes

Posted on October 1, 2010 Written by Annalyn Frame

SOURCE: AdCare

Acquisition Increases AdCare’s Annualized Revenue Run-Rate by $18 Million

SPRINGFIELD, OH–(Marketwire – October 1, 2010) –  AdCare Health Systems, Inc. (NYSE Amex: ADK), a recognized innovator in senior living and health care facility management, has closed the previously announced purchase agreement for two privately-held nursing homes in Gladsden, Alabama for $18.5 million.

The two facilities have a total of 306 beds, which currently generate about $18 million in annualized revenue and are expected to be immediately accretive to earnings. Combined with other transactions closed earlier in the year, AdCare’s estimated annualized revenue run-rate now exceeds $96 million, which represents an increase of approximately 261% from $26.7 million in the year ended 2009.

AdCare financed this purchase through a local bank, with a guarantee by the United States Department of Agriculture (USDA). The guarantee is provided through a program developed by the government to supply long-term financing for rural projects at favorable rates.

“This transaction is the fourth we’ve closed since we began our M&A campaign at the end of last year,” said Chris Brogdon, AdCare’s vice chairman and chief acquisitions officer. “We expect all of our new facilities to be significant cash generators for AdCare, especially as they come under our highly capable management and benefit from our larger economy of scale.”

“As we move toward closing the remaining transactions we announced, additional opportunities continue to emerge in the southern region of the U.S. as well as in the Midwest,” said Brogdon. “We are working to establish the terms and necessary financings for several new potential acquisitions in our pipeline of equal or greater potential.”

Brogdon joined AdCare in September 2009 when the company announced a new M&A growth strategy to build upon its strong reputation for operational efficiency and high-quality living environments.

About AdCare Health Systems
AdCare Health Systems, Inc. (NYSE Amex: ADK) is a recognized innovator in senior living and health care facility management. AdCare develops, owns and manages assisted living facilities, nursing homes and retirement communities, as well as provides home health care services. Since its inception in 1988, AdCare’s mission has been to provide the highest quality of healthcare services to the elderly. For more information about AdCare, visit www.adcarehealth.com.

Important Cautions Regarding Forward-Looking Statements
Statements contained in this press release that are not historical facts may be forward-looking statements within the meaning of federal law. Such statement can be identified by the use of forward-looking terminology, such as “believes,” “expects,” “plans,” “intends,” “anticipates” and variations of such words or similar expressions, but their absence does not mean that the statement is not forward-looking. Statements in this announcement that are forward-looking include, but are not limited to, statements that the company expects all of these new facilities to be significant cash generators for AdCare. Such forward-looking statements reflect management’s beliefs and assumptions and are based on information currently available to management. The forward-looking statements involve known and unknown risks, results, performance or achievements of the Company to differ materially from those expressed or implied in such statements. Such factors are identified in the public filings made by the Company with the Securities and Exchange Commission and include the Company’s ability to secure lines of credit and/or an acquisition credit facility, find suitable acquisition properties at favorable terms, changes in the health care industry because of political and economic influences, changes in regulations governing the industry, changes in reimbursement levels including those under the Medicare and Medicaid programs and changes in the competitive marketplace. There can be no assurance that such factors or other factors will not affect the accuracy of such forward-looking statements.

Company Contact
Chris Brogdon
Vice Chairman & CAO
AdCare Health Systems, Inc.
Tel (937) 964-8974
Email: Email Contact

Investor Relations
Ron Both or Geoffrey Plank
Liolios Group, Inc.
Tel (949) 574-3860
Email: Email Contact

Click here to see all recent news from this company

Filed Under: Medical And Healthcare

Infection Control Leader Zimek Technologies Supports CMS Efforts to Enhance Hospital Quality Standards

Posted on October 1, 2010 Written by Annalyn Frame

SOURCE: Zimek Technologies

TAMPA, FL–(Marketwire – October 1, 2010) –  Zimek Technologies (www.zimek.com), a worldwide leader in infection control and biohazard remediation, today applauded the Center for Medicare and Medicaid Services (CMS) current efforts toward enhancing hospital quality standards, which among them include driving hospitals to meaningfully reduce healthcare-associated infections (HAIs).

“We support all regulatory efforts that push for a critical need to address HAIs, which according to the Centers for Disease Control (CDC) is a major concern with 3.5 million patients infected each year in hospitals and long-term care facilities due to HAIs,” said Kurt Grosman, CEO of Zimek Technologies. “As a business leader in the infection control industry, I intend to support the CMS by promoting meaningful infection control best practices which can reduce HAIs and save lives. Zimek’s state of the art infection control technology can clearly help hospitals all over the country meet the quality standards set forth by CMS to reduce overall Hospital-Acquired Conditions (HACs).” Last week, CMS suspended its plans to make HAC information available to the public due to a discrepancy which was identified between the claims data that hospitals submitted and the CMS data file that was used to calculate the HAC information.

Grosman pointed out that by utilizing Zimek Technologies, hospitals can save millions of dollars annually. “Preventing five of the most commonly occurring HACs could help a 200-bed facility save $2 million a year, which is documented by the Healthcare Management Council (HMC),” Grosman said. The savings relate to the extra services hospitals provide to treat related complications that arise. Infection due to medical care is one of the HACs that can result in nonpayment from Medicare, Medicaid, and in some cases private insurance.

In data provided by the Agency for Healthcare Research and Quality, HMC studied hospitals as small as 75 beds and as large as 800 beds to determine how much they spend on HAC-related patient care. The cost ranged from $8,300 per patient for care costs associated with accidental punctures to $24,500 per patient for care related to hospital-acquired infections.

Zimek’s industry-leading infection control technologies are used by the U.S. Department of Homeland Security, Department of Defense, fire and EMS departments, healthcare facilities, public health agencies, transit systems, correctional facilities, and local law enforcement agencies across America.

Zimek’s revolutionary Micro-Mist® products “micronize” disinfectants that can quickly and automatically decontaminate facilities, equipment and vehicles. Zimek’s germ-killing Micro-Mist® can permeate crevasses and hidden surfaces where super-germs are untouched by standard sanitizing methods.

“Zimek’s proven rapid infection control application is a meaningful 21st century best practices infection prevention technology which will add another weapon to our arsenal to combat the spread of infectious diseases,” Grosman added.

Media Contact:
Bob Mazza
Email Contact
(310) 994-4847

Filed Under: Facilities And Providers

Media Advisory: Suntron Grand Opening Event

Posted on September 30, 2010 Written by Annalyn Frame

SOURCE: Suntron Corporation

METHUEN, MA–(Marketwire – September 30, 2010) –  A ribbon cutting event is occurring at Suntron Corporation’s new manufacturing facility. Join Ed Wheeler, CEO of Suntron; Lt. Governor Timothy P. Murray; Congresswomen Niki Tsongas; Mayor Manzi III and Jose Bevilacqua in the opening event at 1pm, facility tour to follow.

For more information please contact:
Jen Winters
Email Contact
888-520-3382

Filed Under: Medical And Healthcare

Assisted Living Concepts, Inc. Increases and Extends TCF Loan

Posted on September 30, 2010 Written by Annalyn Frame

SOURCE: Assisted Living Concepts, Inc.

MENOMONEE FALLS, WI–(Marketwire – September 30, 2010) – Assisted Living Concepts, Inc. (“ALC”) (NYSE: ALC) announces the expansion and extension of a loan agreement with TCF National Bank (“TCF”). The revised loan agreement increases the loan from $14.0 million to $26.25 million and extends the maturity from June 12, 2014 to September 30, 2015. The loan bears interest at the rate of 6.5% and is secured by mortgages on six of ALC’s senior housing residences.

“We are pleased to have completed a second round of financing with TCF,” commented Laurie Bebo, President and Chief Executive Officer of Assisted Living Concepts, Inc. “Appraisals on the three properties added to secure this loan were in excess of $100,000 per unit, once again demonstrating the value of our business model for owned properties. We own 46 additional unencumbered properties.” 

About Us
Assisted Living Concepts, Inc. and its subsidiaries operate 211 senior living residences comprising 9,280 residents in 20 states. ALC’s senior living facilities typically consist of 40 to 60 units and offer residents a supportive, home-like setting and assistance with the activities of daily living. ALC employs approximately 4,100 people.

Forward-looking Statements
Statements contained in this release other than statements of historical fact, including statements regarding anticipated financial performance, business strategy and management’s plans and objectives for future operations, including management’s expectations about improving occupancy and private pay mix, are forward-looking statements. Forward-looking statements generally include words such as “expect,” “point toward,” “intend,” “will,” “indicate,” “anticipate,” “believe,” “estimate,” “plan,” “strategy” or “objective.” Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied. In addition to the risks and uncertainties referred to in the release, other risks and uncertainties are contained in ALC’s filings with United States Securities and Exchange Commission and include, but are not limited to, the following: changes in the health care industry in general and the senior housing industry in particular because of governmental and economic influences; changes in general economic conditions, including changes in housing markets, unemployment rates and the availability of credit at reasonable rates; changes in regulations governing the industry and ALC’s compliance with such regulations; changes in government funding levels for health care services; resident care litigation, including exposure for punitive damage claims and increased insurance costs, and other claims asserted against ALC; ALC’s ability to maintain and increase census levels; ALC’s ability to attract and retain qualified personnel; the availability and terms of capital to fund acquisitions and ALC’s capital expenditures; changes in competition; and demographic changes. Given these risks and uncertainties, readers are cautioned not to place undue reliance on ALC’s forward-looking statements. All forward-looking statements contained in this report are necessarily estimates reflecting the best judgment of the party making such statements based upon current information. ALC assumes no obligation to update any forward-looking statement.

Filed Under: Medical And Healthcare

  • « Previous Page
  • 1
  • …
  • 34
  • 35
  • 36
  • 37
  • 38
  • …
  • 68
  • Next Page »

Search Our Site

Categories

  • AARP
  • AI
  • Blue Cross Blue Shield
  • Canadian Health Care System
  • CIGNA HealthCare
  • COVID-19
  • Facilities And Providers
  • FDA
  • Health Clinics
  • Healthcare Companies
  • Healthcare Plan News
  • Humana
  • MedBasics
  • Medical And Healthcare
  • Medical Malpractice
  • Medicare
  • Senior News
  • The SCOOTER Store

Pages

  • 1199 National Benefit Fund
  • A Little about Drug Preparation and Formulation Development
  • About Us
  • Achieve Your Weight Goals with Advanced Thermogenic with NMN
  • Affordable Health Insurance
  • Anavar: A Deep Dive into Athletic Benefits, Potential Side Effects, and Weight Loss Applications
    • Anavar Cycle: Benefits, Dosages, and Side Effects
      • Anavar Cycle: Benefits, Dosages, and Side Effects
    • Deca Durabolin vs Anavar: Comparing Performance Enhancers
  • B12 Elite Elixir: Vitalizing Your Health and Energy Levels
  • Benefits of Hiring a Senior Caregiving Service
  • Catastrophic Health Insurance
  • Cheap Health Insurance
  • Cheap Health Insurance Plans
  • Child Health Insurance Plans
  • Choosing a Health Insurance Plan
  • Christian Health Insurance
  • Dental Assistants and Their Future
  • Disclaimer
  • Dr. Howard Bellin: Questions about Rhinoplasty
  • Elite Health Online Dual Stack approach: Unlock your weight loss potential
  • Elite Thermogenic Formula: A Game-Changer in Weight Management and Metabolic Health
  • Finding the Right Dentist
  • Get Your Winks in Blink
  • Harnessing the Power of HGH for Vitality and Youthfulness
  • Health Insurance
  • Health Insurance Plans For Family
  • Health Sharing Plans
  • Healthcare and Hospitals: Disinfection is Key
  • High Deductible Health Plans
  • Home Care Employment in Arizona
  • Hormone Replacement Therapy
    • Harmonizing Body and Spirit: Navigating through Hormone Replacement Therapy
    • Hormone Replacement Therapy (HRT) – A Double-Edged Sword
    • Hormone Replacement Therapy (HRT): A Guide to Rebalancing Hormones
    • Hormone Replacement Therapy (HRT): Balancing the Benefits, Side Effects, and Menopausal Relief
    • Hormone Replacement Therapy: Benefits & Considerations
  • Hot ROCS: The Ultimate Solution for Enhanced Energy and Metabolism
  • How A Medical Weight Loss Plan Can Help You Get The Figure You Want
  • How Ketamine Therapy Helps Fight Depression
  • How Orthotic Insoles Improve Your Health
  • Individual Health Insurance Plans
  • John Kim Austin
  • Ketamine Uses and Benefits
  • List of Health Insurance Companies
  • Low Income Health Insurance
  • Medical Device CROs: The Role in Research and Development
  • Medical Malpractice
  • Medical Research Consultants
  • Menopause and HRT
  • Mounjaro (Tirzepatide): A Breakthrough in Diabetes and Obesity Management
  • Nicotinamide Adenine Dinucleotide – Unleashing Vital Molecule Power for Optimal health
    • Unlocking the Power of NMN in Our Advanced Thermogenic and NMN Formula
  • Oxytocin Benefits
    • Oxytocin: The Love Hormone Decoded
    • Oxytocin: The Love Hormone’s Role in Bonding and Beyond
  • Oxytocin Benefits and Hormone Therapy
  • Peptides: The Future of Health and Wellness
    • Semax Peptide – A Glimpse into Nootropic Advancements
  • Personal Lubricants for Women – Liven Up Your Life!
  • Phentermine: Benefits, Usage, and Potential Side Effects
  • Privacy Policy
  • Private Health Insurance Plans
  • Rapamycin, the anti-aging marvel and its multidimensional health benefits
    • Rapamycin: The Anti-Aging Wonder Drug
  • Rhesus Negative
  • Self Employed Health Insurance
  • Semaglutide: A Safe and Effective Alternative to Surgical Weight Loss
    • Semaglutide and its Weight Loss Benefits
    • Semaglutide: A Revolutionary Treatment Explored
    • Semaglutide: Bridging Diabetes Treatment and Weight Loss While Managing Side Effects
    • Semaglutide: Revolutionizing Weight Loss and Diabetes Management
    • Semaglutide: Transforming Weight Management and Glycemic Control
  • Short Term Health Insurance Plans
  • Student Health Insurance Plans
  • Temporary Health Insurance
  • Terms of Use
  • Testosterone Replacement Therapy Insights
    • Exploring the HCG Diet: Unveiling a Unique Pathway Towards Weight Management
    • Testosterone for Females: Balancing Health & Wellness
      • Testosterone for Females: Exploration of Hormonal Balance and Health
    • Testosterone Replacement Therapy (TRT): A Comprehensive Guide
    • Unlocking the Pivotal Role of Testosterone in Holistic Wellbeing
  • Testosterone Therapy: Weighing the Benefits, Risks, and Identifying Symptoms
    • The Vital Role of Testosterone in Health & Well-being
  • The Basic Building Blocks For a Sustained, Healthy Diet
  • The Importance of Clinical Study Software
  • The Marvels and Misgivings of Rapamycin: A Glimpse into Anti-aging and Longevity Benefits
  • The Use of Post Cycle Therapy Supplements
  • Timeless Beauty Med Spa: Elevating Skincare in Dallas, Texas
    • Achieve Your Body Goals with Emsculpt Neo: Now Available at Timeless Beauty Med Spa in Dallas, Texas
    • The Ultimate Guide to Facials: A Path to Radiant Skin
  • Travel Health Insurance
  • Ultimate Guide for Anavar Cycles
  • Understanding Metformin: Benefits and Insights
    • Metformin: A Pillar of Hope in Weight Loss Journeys
    • Metformin: The Multifaceted Medication for Modern Health Challenges
  • Understanding Nandrolone: Benefits and Uses
    • Demystifying Nandrolone: Uses, Potential Benefits, and Considerations
    • Nandrolone for Joint Pain: Efficacy, Benefits, and Considerations
    • Nandrolone: From Muscle Building to Therapeutic Uses and Side Effects
  • Unleash your Potential with Nandrolone & Deca Durabolin
  • Unleashing Glutathione’s Power: The Key to Anti-Aging and Health
  • Unlocking Testosterone’s Power: A Comprehensive Guide to Better Health
  • Winstrol – Beyond the World of Bodybuilding
    • Unlocking the Potential of Winstrol: Dosage, Benefits, and Risks

Entity Map

Disclaimer

All content on Health Plan News and information provided on this website is for informational purposes only and is not intended as a substitute for advice from your physician or other healthcare professional. You should not use the information on this site for diagnosis or treatment of any health problem or for prescription of any medication or other treatment. Always consult with a healthcare professional before starting any diet, exercise, or supplementation program, before taking any medication, or if you have or suspect you might have a health problem.

Copyright © 2026 - Privacy Policy - Terms of Use - Disclaimer